Renalytix Plc (AIM:RENX)
London · Delayed Price · Currency is GBP · Price in GBX 3.300
-0.050 (-1.49%)
Mar 6, 2026, 12:12 PM GMT
Renalytix Market Cap
Renalytix has a market cap or net worth of 14.64 million as of March 6, 2026. Its market cap has decreased by -61.56% in one year.
Market Cap
14.64M
Enterprise Value
18.00M
Revenue
2.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.30
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 14.64M, a decrease of -77.33%. That is a compound annual growth rate of -18.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 14.64M | -43.22% |
| Dec 31, 2025 | 25.78M | -27.58% |
| Dec 31, 2024 | 35.60M | 129.87% |
| Dec 29, 2023 | 15.49M | -71.47% |
| Dec 30, 2022 | 54.30M | -87.89% |
| Dec 31, 2021 | 448.32M | 27.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 234.01B |
| GSK plc | 85.07B |
| Haleon | 34.64B |
| Smith & Nephew | 11.35B |
| Sareum Holdings | 21.40M |
| Inspiration Healthcare Group | 20.71M |
| Cambridge Cognition Holdings | 17.79M |
| Fusion Antibodies | 17.50M |